12 Recruiting B-cell Acute Lymphoblastic Leukemia Phase 1 Clinical Trials
Active phase 1 studies for b-cell acute lymphoblastic leukemia enrolling across the USA. Verify eligibility and contact site coordinators.
All B-cell Acute Lymphoblastic Leukemia studiesPhase 1 Studies for B-cell Acute Lymphoblastic Leukemia
A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Venetoclax Plus Inotuzumab for B-ALL
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Study Of KITE-753 in R/R B-Cell ALL
📍 UT MD Anderson — Houston, Texas
View Study & Checklist ➔A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
View Study & Checklist ➔Co-administration of CART22-65s and huCART19 for B-ALL
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
View Study & Checklist ➔Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
📍 City of Hope — Duarte, California
View Study & Checklist ➔CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
📍 Children's Hospital Colorado — Aurora, Colorado
View Study & Checklist ➔ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
📍 Children's Hospital Colorado — Aurora, Colorado
View Study & Checklist ➔Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
📍 University of California, Los Angeles (UCLA) - Medical Center — Los Angeles, California
View Study & Checklist ➔Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
📍 Children's Hospital Los Angeles ( Site 1006) — Los Angeles, California
View Study & Checklist ➔